RT Journal Article
SR Electronic
T1 Biallelic mutation of <em>SUPV3L1</em> causes an inherited leukodystrophy-associated neurodevelopmental disorder due to aberrant mitochondrial double stranded RNA processing
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.07.03.23291502
DO 10.1101/2023.07.03.23291502
A1 Green, Lydia
A1 Hamilton, Noémie
A1 Elpidorou, Marilena
A1 Harris, Erica L.
A1 Douglas, Andrew
A1 Ounap, Katrin
A1 Maroofian, Reza
A1 Rose, Ailsa M.S.
A1 Elworthy, Stone
A1 Renshaw, Stephen A
A1 Low, Elizabeth C.
A1 Prescott, Trine
A1 Soberg, Kristoffer
A1 Al-Maawali, Almunder
A1 Al-Zuhaibi, Sana
A1 Futaisi, Amna Al
A1 Calame, Daniel
A1 Al-Thihli, Khalid
A1 Sheridan, Eamonn G.
A1 Johnson, Colin A.
A1 Livingston, John
A1 Crow, Yanick J.
A1 Poulter, James A
YR 2023
UL http://medrxiv.org/content/early/2023/07/03/2023.07.03.23291502.abstract
AB Inherited white matter disorders (IWMD), or leukodystrophies (LD), are genetic disorders primarily affecting the white matter of the central nervous system (CNS), with or without peripheral nerve involvement. Recent developments in novel gene discovery has led to a greater understanding of myelin biology, with an increasing number of proteins with a wide variety of functions, involved in myelin development, maintenance and function. Here we describe 12 individuals from 9 families diagnosed with a neurodevelopmental disorder in whom biallelic variants in SUPV3L1 have been identified. SUPV3L1 encodes an RNA helicase with previous studies showing a key role in the mitochondrial degradosome. We found patient mutations led to an increase in mitochondrial double stranded RNAs in human cells and supv3l1 knock-out zebrafish confirmed a role in neurodevelopment, with gross defects identified in mitochondrial biogenesis and microglial function. Zebrafish displayed a significant activation of the Type 1 interferon pathway, which was later also confirmed by qPCR on blood RNA from biallelic SUPV3L1 patients. Altogether we describe the clinical spectrum associated with biallelic SUPV3L1 mutations and show the mutations identified result in increased mitochondrial double stranded RNA, altered mitochondrial biogenesis, dysplastic microglia and activation of the type 1 interferon innate immune pathway.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was funded by a Sir Jules Thorn Award for Biomedical Research (JTA/09 to E.G.S and C.A.J.), a University of Leeds Academic Fellowship (to J.A.P), a University of Leeds PhD studentship (to M.E) and a White Rose Universities Collaboration grant (to N.H. and J.A.P). J.A.P is supported by a UKRI Future Leaders Fellowship (MR/T02044X/1). N.H. is supported by a grant from The Legacy of Angels. S.A.R is supported by a Medical Research Council grant to SHIELD consortium MR/NO2995X/1.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Yorkshire &amp; Humber Leeds East Research Ethics Committee (REC ref. 18/YH/0070).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors